Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Desai, Akshay
Item TypeName
Academic Article Diabetes and heart failure: epidemiology, pathophysiology and management.
Academic Article Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit.
Academic Article Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.
Academic Article Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.
Academic Article Race influences the safety and efficacy of spironolactone in severe heart failure.
Academic Article Spironolactone for heart failure with preserved ejection fraction.
Academic Article Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
Academic Article Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
Academic Article Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
Academic Article Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
Academic Article Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.
Academic Article Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial.
Academic Article QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
Academic Article Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Academic Article Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.
Academic Article After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.
Academic Article Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
Academic Article Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.
Academic Article Treatment of Hyperkalemia in Heart Failure.
Academic Article Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.
Academic Article Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
Academic Article Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.
Academic Article Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Academic Article The frailty syndrome and outcomes in the TOPCAT trial.
Academic Article Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Academic Article Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction.
Academic Article Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.
Academic Article Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin?+?Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study).
Academic Article Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction.
Academic Article Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial.
Academic Article Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
Academic Article Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure.
Academic Article Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study.
Academic Article Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
Academic Article Associations Between Depressive Symptoms and HFpEF-Related Outcomes.
Academic Article Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
Academic Article Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.
Academic Article Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
Search Criteria
  • Receptors Mineralocorticoid
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.